Category: Drug Development
Drug Development market research reports by GlobalData
-
Esophageal Cancer: Competitive Landscape
Esophageal Cancer: Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Esophageal Cancer therapeutics. In 2024, more than 410,000 diagnosed incident cases of EC are anticipated in the 16 countries covered in GlobalData’s epide ... Read More
-
AI in Healthcare - Thematic Intelligence
AI in Healthcare - Thematic Intelligence Summary Artificial intelligence (AI) is a fast-growing industry. GlobalData expects every segment of the AI market to grow over the next decade. According to GlobalData forecasts, the AI market was worth $103 billion in 2023. By 2030, it will have grown at ... Read More
-
Pharmaceutical Drug Development Annual Review - 2023
Pharmaceutical Drug Development Annual Review - 2023 Summary This report investigates the year 2023 in the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based ana ... Read More
-
Thematic Intelligence: Rare Disease
Thematic Intelligence: Rare Disease Summary In recent years, there has been growing recognition of the importance of rare diseases as a global health priority, leading to increased research efforts, policy initiatives, and collaborative partnerships aimed at accelerating progress in this field. Key ... Read More
-
Looking Ahead to 2024 - the Future of Pharma
Looking Ahead to 2024 - the Future of Pharma Summary This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, an ... Read More
-
New Prescription - Generative AI meets Healthcare (Vol. 2)
New Prescription - Generative AI meets Healthcare (Vol. 2) Summary GlobalData's latest Innovation Radar report New Prescription: Generative AI Meets Healthcare (Vol. 2), expands upon its predecessor and digs further into the transformative capabilities of generative AI within the pharmaceutical and ... Read More
-
Current and Future Landscape of RNA-Based Drugs and Impact of COVID-19 Vaccines Success
Current and Future Landscape of RNA-Based Drugs and Impact of COVID-19 Vaccines Success Summary This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements ... Read More
-
Startup Series - Tech, genes, and beyond - transforming biotech
Startup Series - Tech, genes, and beyond - transforming biotech Summary Biotechnology is crucial in solving global challenges and enhancing human well-being in medicine, agriculture, and environmental sustainability. Startups are leading the way, driven by healthcare demands, government support, and ... Read More
-
Ewing Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Ewing Sarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Ewing Sarcoma therapeutics. There will be only 9,457 diagnosed prevalent cases of ES in 2023 in the ... Read More
-
Generative Artificial Intelligence (AI) Meets Healthcare - New Prescription
Generative Artificial Intelligence (AI) Meets Healthcare - New Prescription Summary Pharma and healthcare sectors are getting a tech makeover with generative AI. From crunching massive data sets for R&D breakthroughs to mimicking human speech for improved patient care, this technology is making wave ... Read More
-
Future of Pharma - Looking Ahead to 2023
Future of Pharma - Looking Ahead to 2023 Summary This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and mar ... Read More
-
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in bladder cancer therapeutics. Synopsis In 2022, there will be more than 460,000 diagnosed incident c ... Read More
-
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H2 2022
Coronavirus Disease 2019 (COVID-19) Analyst Consensus Sales Analysis and Forecast, H2 2022 Summary This report contains a summary of the analyst consensus forecasts available in the GlobalData Pharma Intelligence Center Drug Sales and Analyst Consensus Database for the Indication COVID-19. Currently ... Read More
-
Non-Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Non-Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in NSCLC therapeutics. Synopsis In 2022, there will be more than 1.5 million diagnosed pre ... Read More
-
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Esophageal Cancer therapeutics. Synopsis In 2022, there will be more than 440,000 diagnosed prev ... Read More
-
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - August 2022
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - August 2022 Summary The Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer looks at the data from clinical trials for vaccines and therapeutics either currently marketed or in the pipeline. The data is assessed, ... Read More
-
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research Summary The Genomics Landscape Continues to Be Dynamic in Q2 2022 With Less Activity Seen in Immuno-oncology. The genomics landscape was active in Q2 2022, with scores increased for several companies. This includes ... Read More
-
Artificial Intelligence (AI) in Drug Discovery - Thematic Research
Artificial Intelligence (AI) in Drug Discovery - Thematic Research Summary In recent years, driven by the COVID-19 pandemic, the pharma industry has undergone increased levels of digital transformation. The availability of ultra-large datasets and technological advances has led to more interest in t ... Read More
-
Clinical Trials - Where are we Headed with COVID-19 Trials?
Clinical Trials - Where are we Headed with COVID-19 Trials? Summary This report provides an overview of global COVID-19 clinical trials extracted from the GlobalData Pharma Intelligence Center on March 30, 2022. The purpose of this report is to provide insight into the overall clinical trial landsca ... Read More
-
Neuroimmunology Drug Development - Thematic Research
Neuroimmunology Drug Development - Thematic Research Summary This report provides an overview of neuroimmunology drug development within eight key indications across eight pharmaceutical markets. The neuroimmune system is complex and a critical component in regulating nervous system health and disea ... Read More
-
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - March 2022
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - March 2022 Summary When faced with an outbreak of a pathogen with no known treatments, we are forced to rely on the pharmaceutical industry to develop interventions to curb these potential disasters. The COVID-19 Clinical and Com ... Read More
-
Gastroparesis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2026
Gastroparesis Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2026 Summary In gastroparesis Dopamine (D2) receptor is a major focus of drug developers. There are 17 drugs in the pipeline with 90% molecules present in early stage. Mid-sized Pharma ... Read More
Research Assistance
